KDR and neoplasm: VEGF-A and VEGFR2 expression in prostate cancer are regulated by many factors present in the tumor microenvironment, including acetyl-L-carnitine, which downregulates the VEGF-A and other angiogenic pathways in prostate cancer cells [65].